Machine learning in antimicrobial therapy for critically ill patients: optimizing early empirical regimens, individualized dosing, and de-escalation strategies
Authors:
- 25 September 2025
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 66 (6) , 107632
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Use of Machine Learning for Dosage Individualization of Vancomycin in NeonatesClinical Pharmacokinetics, 2023
- Foundations of Machine Learning-Based Clinical Prediction Modeling: Part II—Generalization and Overfitting2021
- Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual PredictionClinical Pharmacokinetics, 2021
- Fast screening of covariates in population models empowered by machine learningJournal of Pharmacokinetics and Pharmacodynamics, 2021
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#Intensive Care Medicine, 2020
- Artificial Intelligence and Machine Learning: Will Clinical Pharmacologists Be Needed in the Next Decade? The John Henry QuestionClinical Pharmacology & Therapeutics, 2020
- Model‐Informed Artificial Intelligence: Reinforcement Learning for Precision DosingClinical Pharmacology & Therapeutics, 2020
- Pharmacometrics and Machine Learning Partner to Advance Clinical Data AnalysisClinical Pharmacology & Therapeutics, 2020
- Duration of Exposure to Antipseudomonal β‐Lactam Antibiotics in the Critically Ill and Development of New ResistancePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2018
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Medicine, 2017